Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901874 · ClinicalTrials.gov registry record · NA
The Gore SCAFFOLD Clinical Study
A NA study of Carotid Artery Disease and Carotid Artery Stenosis, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 312
- Enrollment target
- 2
- Study locations
NCT01901874 is a NA study of Carotid Artery Disease and Carotid Artery Stenosis that has completed, run by W.L.Gore & Associates. The registered enrollment target is 312 participants, below the 13,671-participant average among 5 other Carotid Artery Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01901874, a NA study of Carotid Artery Disease and Carotid Artery Stenosis, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 312 participants
- Enrollment target
- 2
- Study locations
Study Summary
Evaluate the safety and efficacy of the GORE® Carotid Stent for the treatment of carotid artery stenosis in patients at increased risk for adverse events from carotid endarterectomy
Conditions Studied
Interventions
- DEVICE Carotid Artery Stenting
Study Locations (2)
Hawaii
- Kaiser Permanente Hawaii - Honolulu
Pennsylvania
- Lankenau Heart Institute - Wynnewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2013-07 |
| Est. Completion | 2020-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01901874
The ClinicalTrials.gov registry entry for NCT01901874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,671-participant average among 5 other Carotid Artery Disease trials with a reported enrollment target (98% lower). The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Carotid Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Carotid Artery Stenting is the first listed.
NCT01901874 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Hawaii, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01901874 about?
NCT01901874 is a clinical study titled "The Gore SCAFFOLD Clinical Study". Evaluate the safety and efficacy of the GORE® Carotid Stent for the treatment of carotid artery stenosis in patients at increased risk for adverse events from carotid endarterectomy
What is the current status of trial NCT01901874?
This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2013-07. Estimated completion is 2020-09.
What conditions does trial NCT01901874 study?
This clinical trial studies the following conditions: Carotid Artery Disease, Carotid Artery Stenosis.
What interventions are being tested in trial NCT01901874?
The interventions under investigation include: Carotid Artery Stenting (DEVICE).
Who is sponsoring clinical trial NCT01901874?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01901874 being conducted?
This trial has 2 study locations across Hawaii, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Carotid Revascularization With ev3 Arterial Technology Evolution Post Approval Study
COMPLETED · NA
-
Assessment Of Vascular Health After Niacin Therapy (AVANT)
COMPLETED · NA
-
SVS VQI TransCarotid Revascularization Surveillance Project
RECRUITING
-
CAPTURE 2 Post-Marketing Registry
COMPLETED
-
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.